PHARMACIST'S PERSPECTIVE ON RECENT LABELING CHANGES REQUIRED BY FDA FOR OVER-THE-COUNTER INTERNAL ANALGESIC, ANTIPYRETIC AND ANTIRHEUMATIC DRUGS

被引：0

|

作者：

Bhattacharya, R. ^{[1
]}

Shah, A. ^{[1
]}

Kadakia, A. ^{[1
]}

Gupta, P. ^{[1
]}

Sansgiry, S. S. ^{[1
]}

机构：

[1] Univ Houston, Houston, TX USA

来源：

VALUE IN HEALTH | 2010年 / 13卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)72462-1

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

收藏

页码：A96 / A97

页数：2

相关论文

共 4 条

[1] The FDA's proposed labeling rules for over-the-counter drugs and preemption of state tort law
Rissier, JW
SOUTHERN CALIFORNIA LAW REVIEW, 1998, 71 (06) : 1387 - 1428
[2] Pharmacist's Evolving Role in the Nonopioid, Over-the-Counter, Analgesic Selection Process
Barkin, Robert L.
AMERICAN JOURNAL OF THERAPEUTICS, 2015, 22 (06) : 423 - 430
[3] Manufacturers' compliance with the US food and drug administration's Over-The-Counter Human Drugs:: Labeling Requirements
Sansgiry, SS
Shringarpure, G
PACKAGING TECHNOLOGY AND SCIENCE, 2003, 16 (03) : 91 - 98
[4] Changes in pharmacist's recommendations of over-the-counter treatments for the common cold during the COVID-19 pandemic
Kopa-Stojak, Paulina Natalia
Pietrusiewicz, Malgorzata
Pawliczak, Rafal
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (05) : 767 - 773